mockupThis story is a mockup. The patient shown is fictional, as is every date, result and document below.
Anna's story
How Anna noticed the first symptoms, how the diagnosis was finally pinned down, and what daily life with eosinophilic fasciitis looks like now. Published with Anna's permission, redacted of third-party data.
Released under CC BY-SA 4.0 with Anna's written consent. Third-party identifiers, the names of attending clinicians, and the issuing hospital's logos and registration numbers are blacked out on every page.
The first sign was not pain — it was a forearm that no longer rotated the way it used to.
For Anna, the first sign was not pain. It was the slow, stubborn refusal of a forearm to rotate the way it always had — a piece of the body that, almost overnight, no longer belonged to the person inside it. The skin felt thicker. The morning stiffness lasted into the afternoon.
Three doctors in, the working diagnoses had cycled through overuse, an autoimmune skin disease, and, briefly, a hypochondria-shaped silence at the end of an appointment. The blood count that eventually broke the stalemate showed marked eosinophilia — the single laboratory clue that points away from scleroderma and towards M35.4. From there, the path was clear: rheumatology, MRI, fascial biopsy, diagnosis.
The disease that Anna now lives with has a name, a code, and a small but real body of evidence behind its treatment. That alone, as Anna has said, is worth more than people without a rare disease usually realise.
From first symptom to a stable plan.
First symptoms, first doctors
Anna noticed the change but did not yet have a name for it. Primary-care visits, a working diagnosis that did not fit, and the slow accumulation of evidence that this was not what anyone first thought.
Eosinophilia, then a rheumatologist
A peripheral blood count drew attention to the eosinophil line. A referral followed. The first rheumatologist Anna saw recognised the clinical pattern within two appointments and ordered an MRI of the affected limb.
MRI, fascial biopsy, diagnosis
T2-STIR imaging of the affected limbs showed the fascia lit up. The biopsy confirmed the dense lymphoplasmacytic and eosinophilic infiltrate sparing the dermis and muscle. ICD-10 M35.4 entered Anna's records.
Treatment, taper, daily life
First-line glucocorticoids, then a steroid-sparing agent. Anna is now on a stable maintenance regimen and has returned to most of the things that the worst months had taken away.
Three panels, redacted.
Immunoglobulins (IgG, IgA, IgM, IgE)
ANA / ENA / anti-Scl-70 — negative
MRI of the affected limb.
Affected limb — T2-STIR, coronal
Affected limb — post-contrast T1, axial
The diagnostic admission.
Full-thickness skin-to-muscle biopsy of the affected forearm under local anaesthesia. Histopathology: thickened, inflamed fascia with a dense lymphoplasmacytic and eosinophilic infiltrate, dermis and muscle spared. Oral prednisolone 1 mg/kg/day initiated before discharge. Follow-up at four weeks.
First line, then a steroid-sparer.
Oral prednisolone, then subcutaneous methotrexate
Eosinophil count normalised at week 4. Methotrexate 15 mg/week added at month 6 to permit a steroid taper. Maintenance: prednisolone 5 mg/day + methotrexate 15 mg/week. Disease stable for the past 14 months.
Six months into treatment.
What Anna would tell
the next patient.
“The hardest part was not the diagnosis. The hardest part was the months before the diagnosis, when no one believed there was anything wrong.” Anna has said this in three different ways across the conversations behind this page. It is the closest thing to a moral the story has.
If you are reading this and your own symptoms have been brushed off, Anna wants you to know: ask for an eosinophil count. It is a cheap test. It will not, on its own, prove anything — but it can be the single number that finally points the differential in the right direction.
Mockup notice — this page is a demonstration of the case-page template. The narrative is composite; the medical pattern (eosinophilia, MRI, fascial biopsy, glucocorticoid-first treatment) is consistent with the published literature on M35.4. Document codes, dates and outcomes are placeholders.
Read the other stories, or write to the site author.
This patient story is a mockup
What you see below is only a mockup — a preview of how an individual patient's story might look in the future.
It does not describe a real person. The patient shown here is fictional, and so is every date, result, document and image on the page.
Nothing on this page is a medical record, and nothing on it is medical advice.
Tick the box above to unlock the story.